Quantification of torque teno virus viremia as a prospective biomarker for infectious disease in kidney allograft recipients

R Strassl, M Schiemann, K Doberer… - The Journal of …, 2018 - academic.oup.com
Background Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients.

R Strassl, M Schiemann, K Doberer… - The Journal of …, 2018 - europepmc.org
Background Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients

R Strassl, M Schiemann, K Doberer… - The Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients

R Strassl, M Schiemann, K Doberer, I Görzer… - The Journal of Infectious …, 2018 - JSTOR
Background. Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

Quantification of torque teno virus viremia as a prospective biomarker for infectious disease in kidney allograft recipients.

R Strassl, M Schiemann, K Doberer, I Görzer… - 2018 - cabidigitallibrary.org
Background: Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

Quantification of torque teno virus viremia as a prospective biomarker for infectious disease in kidney allograft recipients.

R Strassl, M Schiemann, K Doberer, I Görzer… - Journal of Infectious …, 2018 - cabdirect.org
Background: Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

[PDF][PDF] Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients

R Strassl, M Schiemann, K Doberer… - The Journal of …, 2018 - academic.oup.com
Background Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

[HTML][HTML] Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients

R Strassl, M Schiemann, K Doberer… - The Journal of …, 2018 - ncbi.nlm.nih.gov
Background Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients.

R Strassl, M Schiemann, K Doberer… - The Journal of …, 2018 - europepmc.org
Background Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …

Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients

R Strassl, M Schiemann, K Doberer, I Görzer… - The Journal of Infectious …, 2018 - JSTOR
Background. Drug-induced immunosuppression following kidney transplantation is crucial to
prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing …